Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Kyverna Therapeutics Inc (NASDAQ: KYTX) was $2.39 for the day, up 15.46% from the previous closing price of $2.07. In other words, the price has increased by $15.46 from its previous closing price. On the day, 1.0 million shares were traded. KYTX stock price reached its highest trading level at $2.4199 during the session, while it also had its lowest trading level at $2.08.
Ratios:
Our analysis of KYTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.44 and its Current Ratio is at 7.44. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 10, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On October 09, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16.
On July 03, 2024, H.C. Wainwright started tracking the stock assigning a Neutral rating and target price of $8.H.C. Wainwright initiated its Neutral rating on July 03, 2024, with a $8 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYTX now has a Market Capitalization of 103293176 and an Enterprise Value of -132417896.
Stock Price History:
The Beta on a monthly basis for KYTX is 1.85, which has changed by -0.8207052 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, KYTX has reached a high of $17.06, while it has fallen to a 52-week low of $1.78. The 50-Day Moving Average of the stock is 10.07%, while the 200-Day Moving Average is calculated to be -43.27%.
Shares Statistics:
KYTX traded an average of 272.05K shares per day over the past three months and 367750 shares per day over the past ten days. A total of 43.22M shares are outstanding, with a floating share count of 19.55M. Insiders hold about 54.75% of the company’s shares, while institutions hold 25.45% stake in the company. Shares short for KYTX as of 1745971200 were 2136619 with a Short Ratio of 7.85, compared to 1743379200 on 2945611. Therefore, it implies a Short% of Shares Outstanding of 2136619 and a Short% of Float of 8.61.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A comprehensive evaluation of Kyverna Therapeutics Inc (KYTX) is underway, with the input of 5.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.91, with high estimates of -$0.74 and low estimates of -$1.12.
Analysts are recommending an EPS of between -$3.43 and -$4.22 for the fiscal current year, implying an average EPS of -$3.66. EPS for the following year is -$2.77, with 4.0 analysts recommending between -$1.61 and -$3.8.
